rdf:type |
|
lifeskim:mentions |
umls-concept:C0009402,
umls-concept:C0011991,
umls-concept:C0021853,
umls-concept:C0030705,
umls-concept:C0035253,
umls-concept:C0087111,
umls-concept:C0348016,
umls-concept:C0549178,
umls-concept:C0574032,
umls-concept:C0724649,
umls-concept:C1321013
|
pubmed:issue |
5
|
pubmed:dateCreated |
1993-9-16
|
pubmed:abstractText |
A prospective trial was conducted involving 16 patients with colorectal adenocarcinoma using a regimen of continuous-infusion octreotide acetate (Sandostatin [octreotide acetate], Sandoz, East Hanover, NJ for the treatment of severe diarrhea induced by the weekly schedule of 5-fluorouracil (5-FU) in combination with leucovorin who were refractory to opiate therapy.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1543-6
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8348489-Adenocarcinoma,
pubmed-meshheading:8348489-Adult,
pubmed-meshheading:8348489-Aged,
pubmed-meshheading:8348489-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8348489-Colonic Neoplasms,
pubmed-meshheading:8348489-Diarrhea,
pubmed-meshheading:8348489-Female,
pubmed-meshheading:8348489-Fluid Therapy,
pubmed-meshheading:8348489-Fluorouracil,
pubmed-meshheading:8348489-Humans,
pubmed-meshheading:8348489-Infusions, Intravenous,
pubmed-meshheading:8348489-Intestines,
pubmed-meshheading:8348489-Leucovorin,
pubmed-meshheading:8348489-Male,
pubmed-meshheading:8348489-Middle Aged,
pubmed-meshheading:8348489-Octreotide,
pubmed-meshheading:8348489-Prospective Studies,
pubmed-meshheading:8348489-Rectal Neoplasms,
pubmed-meshheading:8348489-Recurrence,
pubmed-meshheading:8348489-Remission Induction,
pubmed-meshheading:8348489-Time Factors
|
pubmed:year |
1993
|
pubmed:articleTitle |
Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.
|
pubmed:affiliation |
Department of Surgical Oncology, Grace Cancer Drug Center, Roswell Park Cancer Institute, Buffalo, New York 14263.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|